Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
combination therapy
Biotech
BioNTech, BMS tout first global data for PD-L1xVEGF drug in SCLC
BioNTech and BMS have picked the pumitamig dose for the Rosetta Lung-01 phase 3 trial in first-line extensive-stage small cell lung cancer.
Angus Liu
Sep 8, 2025 11:00am
Immutep's LAG-3 agent posts 'impressive' survival data
May 5, 2025 10:37am
Amgen and Ideaya ax cancer combination trial
Feb 13, 2025 7:34am
Lilly's oral SERD Ember counts on Verzenio to broaden its glow
Dec 11, 2024 8:15am
Vir keeps pressure on Gilead with midphase hepatitis D data
Jun 5, 2024 8:52am
ASCO: Regeneron misses mark with one CR in solid tumor trial
May 23, 2024 5:00pm
